HCC occurrence after DAA treatments: molecular tools to assess the post-treatment risk and surveillance
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis
2020-06-01
|
Series: | Hepatic Oncology |
Subjects: | |
Online Access: | https://www.futuremedicine.com/doi/10.2217/hep-2020-0010 |